metformin with glp 1 What Next When Isn't Enough For Type 2 Diabetes? Comparative Safety of Metformin-GLP-1 RA

The combination is not random

On Monday, 24th November, Novo Nordisk published a press release, explaining that the Evoke and Evoke+ trials did not confirm superiority of semaglutide versus placebo in the reduction of progression of Alzheimers disease. Although the researchers did report significant reductions in biomarkers associated with Alzheimers, there was no reduction in disease progression in either trial

When fiber reaches the colon, beneficial gut bacteria ferment it into short-chain fatty acids (SCFAs), which stimulate the release of GLP-1

Although some exendin-4-based probes for SPECT and PET imaging showed their utilities in prospective clinical studies 13,14,15,16,17 , exendin-4-based probes with various chemical modifications are still being investigated for further improvement 13,18,19

The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism